-
2
-
-
67349117295
-
EAU guidelines on neurogenic lower urinary tract dysfunction
-
10.1016/j.eururo.2009.04.028. 19403235
-
EAU guidelines on neurogenic lower urinary tract dysfunction. M Stöhrer B Blok D Castro-Diaz, et al. Eur Urol 2009 56 81 88 10.1016/j.eururo.2009.04.028 19403235
-
(2009)
Eur Urol
, vol.56
, pp. 81-88
-
-
Stöhrer, M.1
Blok, B.2
Castro-Diaz, D.3
-
3
-
-
33644915254
-
Pharmacological treatment of urinary incontinence
-
UK, Health Publication Ltd Abrams P, Cardozo L, Khoury S, Wein A. Plymouth, 3
-
Pharmacological treatment of urinary incontinence. KE Andersson R Appell L Cardozo, et al. Incontinence. 3rd International Consultation on Incontinence: 26-29 June 2004 UK, Health Publication Ltd, Abrams P, Cardozo L, Khoury S, Wein A. Plymouth, 3 2005 809 854
-
(2005)
Incontinence. 3rd International Consultation on Incontinence: 26-29 June 2004
, pp. 809-854
-
-
Andersson, K.E.1
Appell, R.2
Cardozo, L.3
-
4
-
-
77957292014
-
Management of urinary incontinence in primary care
-
Royal College of Phyicians
-
Management of urinary incontinence in primary care. Scottish Intercollegiate Guidelines Network, Royal College of Phyicians 2004 http://www.sign.ac.uk
-
(2004)
Scottish Intercollegiate Guidelines Network
-
-
-
5
-
-
68249084476
-
Pharmacological treatment of overactive bladder: Report from the International Consultation on Incontinence
-
10.1097/MOU.0b013e32832ce8a4. 19448545
-
Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence. KE Andersson CR Chapple L Cardozo, et al. Curr Opin Urol 2009 19 380 394 10.1097/MOU.0b013e32832ce8a4 19448545
-
(2009)
Curr Opin Urol
, vol.19
, pp. 380-394
-
-
Andersson, K.E.1
Chapple, C.R.2
Cardozo, L.3
-
6
-
-
47949098266
-
The effects of antimuscarinic treatments in overactive bladder: An update of a systematic review and meta-analysis
-
10.1016/j.eururo.2008.06.047. 18599186
-
The effects of antimuscarinic treatments in overactive bladder: An update of a systematic review and meta-analysis. CR Chapple V Khullar Z Gabriel, et al. Eur Urol 2008 54 543 562 10.1016/j.eururo.2008.06.047 18599186
-
(2008)
Eur Urol
, vol.54
, pp. 543-562
-
-
Chapple, C.R.1
Khullar, V.2
Gabriel, Z.3
-
7
-
-
34247271263
-
Maximizing anticholinergic therapy for overactive bladder: Has the ceiling been reached?
-
10.1111/j.1464-410X.2007.06881.x. 17488367
-
Maximizing anticholinergic therapy for overactive bladder: has the ceiling been reached? S MacDiarmid, BJU Int 2007 99 Suppl 3 8 12 10.1111/j.1464-410X.2007.06881.x 17488367
-
(2007)
BJU Int
, vol.99
, Issue.SUPPL. 3
, pp. 8-12
-
-
MacDiarmid, S.1
-
8
-
-
32444441009
-
Using anticholinergics to treat overactive bladder: The issue of treatment tolerability
-
DOI 10.1016/j.amjmed.2005.12.011, PII S0002934305011915
-
Using anticholinergics to treat overactive bladder: the issue of treatment tolerability. DR Staskin SA MacDiarmid, Am J Med 2006 119 3A 9S 15S 10.1016/j.amjmed.2005.12.011 (Pubitemid 43227968)
-
(2006)
American Journal of Medicine
, vol.119
, Issue.3 SUPPL. 1
-
-
Staskin, D.R.1
MacDiarmid, S.A.2
-
9
-
-
32444448625
-
Pharmacologic management of overactive bladder: Practical options for the primary care physician
-
DOI 10.1016/j.amjmed.2005.12.013, PII S0002934305011939
-
Pharmacological management of overactive bladder: practical options for the primary care physician. DR Staskin SA MacDiarmid, Am J Med 2006 199 3A 24S 28S 10.1016/j.amjmed.2005.12.013 (Pubitemid 43227970)
-
(2006)
American Journal of Medicine
, vol.119
, Issue.3 SUPPL. 1
-
-
Staskin, D.R.1
MacDiarmid, S.A.2
-
10
-
-
1542756575
-
Overactive bladder: Improving the efficacy of anticholinergics by dose escalation
-
10.1007/s11934-003-0025-z. 14622497
-
Overactive bladder: improving the efficacy of anticholinergics by dose escalation. SA MacDiarmid, Curr Urol Rep 2003 4 446 451 10.1007/s11934-003-0025- z 14622497
-
(2003)
Curr Urol Rep
, vol.4
, pp. 446-451
-
-
MacDiarmid, S.A.1
-
11
-
-
67649336782
-
Efficacy and tolerability of add-on trospium chloride in patients with benign prostate syndrome and overactive bladder: A non-interventional trial showing use of flexible dosing
-
10.3834/uij.1944-5784.2009.04.02
-
Efficacy and tolerability of add-on trospium chloride in patients with benign prostate syndrome and overactive bladder: a non-interventional trial showing use of flexible dosing. A Wiedemann G Neumann C Neumeister, et al. UIJ 2009 2 2 10.3834/uij.1944-5784.2009.04.02
-
(2009)
UIJ
, vol.2
, Issue.2
-
-
Wiedemann, A.1
Neumann, G.2
Neumeister, C.3
-
13
-
-
74549185973
-
Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: Results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial
-
10.1016/j.clinthera.2009.11.005. 20109997
-
Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial. M Zellner H Madersbacher H Palmtag, et al. Clin Ther 2009 31 2519 2539 10.1016/j.clinthera.2009.11.005 20109997
-
(2009)
Clin Ther
, vol.31
, pp. 2519-2539
-
-
Zellner, M.1
Madersbacher, H.2
Palmtag, H.3
-
14
-
-
0032829435
-
Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence
-
10.1016/S0022-5347(05)68810-6. 10332441
-
Once daily controlled versus immediate release oxybutynin chloride for urge urinary incontinence. RU Anderson D Mobley B Blank, et al. J Urol 1999 161 6 1809 1812 10.1016/S0022-5347(05)68810-6 10332441
-
(1999)
J Urol
, vol.161
, Issue.6
, pp. 1809-1812
-
-
Anderson, R.U.1
Mobley, D.2
Blank, B.3
-
15
-
-
0032838886
-
Evaluation of a new once-daily formulation of oxybutynin for the treatment of urinary urge incontinence
-
10.1016/S0090-4295(99)00259-9. 10475346
-
Evaluation of a new once-daily formulation of oxybutynin for the treatment of urinary urge incontinence. DM Gleason J Susset C White, et al. Urology 1999 54 3 420 423 10.1016/S0090-4295(99)00259-9 10475346
-
(1999)
Urology
, vol.54
, Issue.3
, pp. 420-423
-
-
Gleason, D.M.1
Susset, J.2
White, C.3
-
16
-
-
0034088434
-
Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence
-
10.1016/S0029-7844(99)00661-4. 10775736
-
Dry mouth with conventional and controlled-release oxybutynin in urinary incontinence. E Versi R Appell D Mobley, et al. Obstet Gynecol 2000 95 718 721 10.1016/S0029-7844(99)00661-4 10775736
-
(2000)
Obstet Gynecol
, vol.95
, pp. 718-721
-
-
Versi, E.1
Appell, R.2
Mobley, D.3
-
17
-
-
33645003584
-
A double-blind randomized dose-response study comparing daily doses of 5, 10 and 15 mg controlled-release oxybutynin: Balancing efficacy with severity of dry mouth
-
10.1111/j.1464-410X.2005.06031.x
-
A double-blind randomized dose-response study comparing daily doses of 5, 10 and 15 mg controlled-release oxybutynin: balancing efficacy with severity of dry mouth. J Corcos R Casey A Patrick, et al. BJU Int 2005 97 520 527 10.1111/j.1464-410X.2005.06031.x
-
(2005)
BJU Int
, vol.97
, pp. 520-527
-
-
Corcos, J.1
Casey, R.2
Patrick, A.3
-
18
-
-
14644417909
-
3-selective receptor antagonist
-
10.1111/j.1464-410X.2005.05343.x. 15705084
-
3-selective receptor antagonist. W Steers J Corcos j Foote, et al. BJU Int 2005 95 580 586 10.1111/j.1464-410X.2005.05343.x 15705084
-
(2005)
BJU Int
, vol.95
, pp. 580-586
-
-
Steers, W.1
Corcos, J.2
Foote, J.3
-
19
-
-
23944452838
-
A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: Results of the STAR trial
-
15990220
-
A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. CR Chapple R Martinez-Garcia L Selvaggi, et al. Eur Urol 2005 48 464 470 15990220
-
(2005)
Eur Urol
, vol.48
, pp. 464-470
-
-
Chapple, C.R.1
Martinez-Garcia, R.2
Selvaggi, L.3
-
20
-
-
42749089770
-
Fesoterodine dose response in subjects with overactive bladder syndrome
-
10.1016/j.urology.2007.12.017. 18342923
-
Fesoterodine dose response in subjects with overactive bladder syndrome. VK Khullar ES Rovner R Dmochowski, et al. Urology 2008 71 839 843 10.1016/j.urology.2007.12.017 18342923
-
(2008)
Urology
, vol.71
, pp. 839-843
-
-
Khullar, V.K.1
Rovner, E.S.2
Dmochowski, R.3
-
21
-
-
72249114712
-
Randomized, double-blind, placebo-controlled trial of flexible-dose fesoterodine in subjects with overactive bladder
-
Erratum in: Urology 2010, 75(6): 1519. 10.1016/j.urology.2009.09.018. 19931895
-
Randomized, double-blind, placebo-controlled trial of flexible-dose fesoterodine in subjects with overactive bladder. RR Dmochowski KM Peters JD Morrow, et al. Urology 2010 75 1 62 68 Erratum in: Urology 2010, 75 (6): 1519 10.1016/j.urology.2009.09.018 19931895
-
(2010)
Urology
, vol.75
, Issue.1
, pp. 62-68
-
-
Dmochowski, R.R.1
Peters, K.M.2
Morrow, J.D.3
-
22
-
-
33744798224
-
Pharmacotherapy for neurogenic detrusor overactivity
-
10.1097/01.phm.0000219229.92056.c2. 16715024
-
Pharmacotherapy for neurogenic detrusor overactivity. MB Chancellor RU Anderson TB Boone, Am J Phys Med Rehabil 2006 85 6 536 545 10.1097/01.phm. 0000219229.92056.c2 16715024
-
(2006)
Am J Phys Med Rehabil
, vol.85
, Issue.6
, pp. 536-545
-
-
Chancellor, M.B.1
Anderson, R.U.2
Boone, T.B.3
-
23
-
-
0037590258
-
Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury
-
12828295
-
Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury. M O'Leary JR Erickson CP Smith, et al. J Spinal Cord Med 2003 26 159 162 12828295
-
(2003)
J Spinal Cord Med
, vol.26
, pp. 159-162
-
-
O'Leary, M.1
Erickson, J.R.2
Smith, C.P.3
-
24
-
-
0347759842
-
Can higher doses of oxybutynin improve efficacy in neurogenic bladder?
-
10.1097/01.ju.0000103274.38694.b1. 14713802
-
Can higher doses of oxybutynin improve efficacy in neurogenic bladder? N Bennett M O'Leary AS Patel, et al. J Urol 2004 171 749 751 10.1097/01.ju. 0000103274.38694.b1 14713802
-
(2004)
J Urol
, vol.171
, pp. 749-751
-
-
Bennett, N.1
O'Leary, M.2
Patel, A.S.3
-
25
-
-
0030442725
-
Muscarinic receptor subtypes and smooth function
-
8981565
-
Muscarinic receptor subtypes and smooth function. RM Eglen SS Hedge N Watson, Pharmacol Rev 1996 48 531 565 8981565
-
(1996)
Pharmacol Rev
, vol.48
, pp. 531-565
-
-
Eglen, R.M.1
Hedge, S.S.2
Watson, N.3
|